Recently, new pharmaceutical innovations have reshaped the weight loss treatment landscape. Among these, the prescription drugs Zepbound and Ozempic have risen in popularity. Both are used to ...

Weight-Loss Drug Zepbound May Work Better in Women Than Men By Dennis Thompson HealthDay Reporter THURSDAY, Sept. 12, 2024 (HealthDay News) -- The injectable weight-loss drug Zepbound appears to ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide ...

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, ...

The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said. Eli Lilly's tirzepatide, sold as Zepbound for weight loss and ...

Sept. 16, 2024 – Tiny bottles of the weight loss drug Zepbound have started arriving in mailboxes across the country. People who order the medicine directly from drugmaker Eli Lilly can pay much ...

Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Eli Lilly (NYSE:LLY) investing $4.5B to create Lilly Med Foundry, with goal of faster drug pipeline and scaling molecules to medicines. Stock outlook mixed.

Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...